Structure Therapeutics Inc.
-
Ticker
GPCR
-
Industry
Biotechnology More
-
Sector
Healthcare More
- Based in South San Francisco, California
Structure Therapeutics is a leading clinical-stage biopharmaceutical company focused on discovering and developing innovative oral treatments for chronic metabolic and pulmonary conditions with significant unmet medical needs. Utilizing its next generation structure-based drug discovery platform, the company has established a scientifically-driven, GPCR-targeted pipeline, featuring two
…More wholly-owned proprietary clinical-stage small molecule compounds designed to surpass the limitations of traditional biologic and peptide therapies and be accessible to more patients around the world.
REPORT RATINGS
4.7 / 5.0 (3)
Structure Therapeutics Inc. reports have an aggregate usefulness score of 4.7 based on 3 reviews.
Structure Therapeutics Inc.
Most Recent Annual Report
MOST RECENT
2023 Annual Report and Form 10K
Older/Archived Annual Reports